Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Leads BCW Index Decline

The BCW Index recorded a 1.42 percent drop this past week, as 12 of the 16 components lost ground. Leading the group of decliners was Bruker BioSciences, which fell 6.1 percent.

Molecular Devices led the four firms that reported gains for the tracking period ended Tuesday, with an increase of 5 percent. The firm reported its fourth-quarter 2005 results earlier today (see briefs).

For the week, the Dow Jones Industrial Average dropped 1.1 percent, the Nasdaq declined 2.3 percent, and the Nasdaq Biotech Index fell 1.3 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(Feb. 7, 2006)
Last Price
(Jan. 31, 2006)
% change
Agilent
A
34.01
33.91
0.29
Applied Biosystems
ABI
27.8
28.34
-1.91
Beckman
BEC
58.32
59.55
-2.07
Bio-Rad
BIO
65.68
67.4
-2.55
Bruker
BRKR
4.62
4.92
-6.10
Fisher Scientific
FSH
66.16
66.87
-1.06
GE
GE
32.31
32.75
-1.34
Harvard Bio
HBIO
4.62
4.78
-3.35
Invitrogen
IVGN
66.86
68.88
-2.93
Molecular Devices
MDCC
30.01
28.59
4.97
PerkinElmer
PKI
22.98
22.74
1.06
Qiagen
QGEN
12.2
11.84
3.04
Sigma
SIAL
63.53
64.88
-2.08
Stratagene
STGN
10.12
10.2
-0.78
Thermo
TMO
33.22
33.64
-1.25
Waters
WAT
40.53
41.95
-3.38
BCW Index Average
35.81
36.33
-1.42
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.